Cambridge Healthtech Institute’s 12th International
Leaders in Biobanking Congress
Innovations to Maintain Integrity and Maximize Investment in Biospecimens
September 16-18, 2020
The availability of quality data and samples is the foundation of all research. In precision medicine, biobanks play a key role in the overall success of research infrastructure. One common challenge in building this infrastructure is the ability to capture,
combine, and curate multiple data sources tied to biosamples. The role of honest broker, the navigation of industry partnerships, and the increased complexity of biospecimen requests – in terms of sample type and associated clinical variables,
plus molecular and multidimensional longitudinal data – have all created new challenges for supplying the biobanking needs of the future.
Cambridge Healthtech Institute’s 12th International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. The event features efforts in large-scale sample
de-identification, data integration, and digital pathology. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for
effective use of biospecimens within today’s cutting-edge biomedical research.
Innovations covered include:
BIOSPECIMEN SCIENCE: MAINTAINING INTEGRITY
Preparing the Biospecimen
Collection
Processing
Isolation
Storage
Purification
Preservation
Case studies
Types of Biosamples
Legacy collections
Specialty collections
Biofluids
Fixed tissue
Frozen tissue
Donors
Disease indications
Data
Annotation
Tracking
Management
Informatics
Analytics
Integration
Software
BIOBANKING MANAGEMENT: MAXIMIZING INVESTMENT
Resources
Scheduling and procurement
Collection and annotation
Specimen processing
Biopreservation protocols
Storage and backup
Requisition and withdrawal
Shipping and distribution
Automation
Informatics tools
Inventory control
Tracking and shipping
Databases
Infrastructure and hardware
LIMS
Data integration
Regulations
Chain of custody
Informed consent
Compliance
International harmony
HIPAA/CLIA/CAP
Hazardous specimens
Custodianship/Long-term storage
ADVANCING BIOMEDICAL RESEARCH: MULTIPLYING INVESTIGATIONS
Leveraging the Biospecimen
Biomarkers of health and disease
Translation from laboratory to clinic
Diagnostic tools
Targets for drug discovery
Tests for drug development
Clinical trials
Case studies
Using the Biospecimen
Extraction of biomolecules
Measuring quality
Fit-for-purpose
Assay development
Assay validation
Omics
Case studies
We encourage the following professionals to submit a title and summary of their experiences to be considered for a presentation:
- Molecular researchers utilizing biospecimens for their research
- Biobankers providing biospecimens, developing biopreservation technologies standards and protocols, and managing resources while navigating regulatory compliance
- R&D researchers and clinical trial professionals collecting, analyzing, and utilizing data
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is March 27, 2020.
All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com
For partnering and sponsorship information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com